|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Eliem Therapeutics, Inc. (ELYM) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
67,060,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$ - $ |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Eliem Therapeutics is a clinical-stage biotechnology company focused on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, psychiatry, epilepsy and other disorders of the peripheral and central nervous systems. Co. is developing a pipeline of clinically differentiated product candidates focused on validated mechanisms of action with therapeutic potential to deliver therapeutics for patients with these disorders. Co.'s two clinical-stage candidates are ETX-810 and ETX-155. ETX-810 is a palmitoylethanolamide prodrug for the treatment of diabetic peripheral neuropathic pain and lumbosacral radicular pain, commonly referred to as sciatica.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
13,008,546 |
| Total Buy Value |
$0 |
$0 |
$0 |
$49,952,817 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
1,242 |
2,441 |
486,506 |
487,751 |
| Total Sell Value |
$1,540 |
$3,111 |
$3,462,032 |
$3,471,014 |
| Total People Sold |
1 |
1 |
2 |
2 |
| Total Sell Transactions |
1 |
2 |
16 |
17 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Pimblett Emily |
SVP, Finance & CAO |
• – – |
2025-06-20 |
4 |
AS |
$1.24 |
$1,540 |
D/D |
(1,242) |
18,888 |
|
- |
|
| Pimblett Emily |
SVP, Finance & CAO |
• – – |
2025-06-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
20,130 |
|
- |
|
| Thomas Stephen Basil |
|
– • – |
2025-03-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
25,093 |
179,188 |
|
- |
|
| Pimblett Emily |
SVP, Finance & CAO |
• – – |
2025-03-20 |
4 |
AS |
$1.31 |
$1,571 |
D/D |
(1,199) |
15,130 |
|
- |
|
| Pimblett Emily |
SVP, Finance & CAO |
• – – |
2025-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
16,329 |
|
- |
|
| Thomas Stephen Basil |
|
– • – |
2025-01-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,188 |
154,095 |
|
- |
|
| Pimblett Emily |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-12-19 |
4 |
AS |
$2.02 |
$2,495 |
D/D |
(1,235) |
11,329 |
|
- |
|
| Pimblett Emily |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-12-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
12,564 |
|
- |
|
| Pimblett Emily |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-09-20 |
4 |
AS |
$8.06 |
$9,741 |
D/D |
(1,191) |
7,564 |
|
- |
|
| Pimblett Emily |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-09-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
8,755 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-22 |
4 |
S |
$7.98 |
$554,170 |
D/D |
(69,005) |
31,317 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-19 |
4 |
S |
$7.09 |
$434,325 |
D/D |
(60,201) |
100,322 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-18 |
4 |
S |
$6.93 |
$267,332 |
D/D |
(38,576) |
160,523 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-17 |
4 |
S |
$6.91 |
$22,160 |
D/D |
(3,207) |
199,099 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-16 |
4 |
S |
$7.13 |
$356,500 |
D/D |
(50,000) |
202,306 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-15 |
4 |
S |
$7.01 |
$297,063 |
D/D |
(42,377) |
252,306 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-12 |
4 |
S |
$7.07 |
$353,500 |
D/D |
(50,000) |
294,683 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-11 |
4 |
S |
$7.11 |
$355,500 |
D/D |
(50,000) |
344,683 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-10 |
4 |
S |
$6.83 |
$341,500 |
D/D |
(50,000) |
394,683 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-09 |
4 |
S |
$6.66 |
$39,500 |
D/D |
(5,931) |
444,683 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-05 |
4 |
S |
$7.06 |
$87,135 |
D/D |
(12,342) |
450,614 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-03 |
4 |
S |
$6.76 |
$338,000 |
D/D |
(50,000) |
462,956 |
|
- |
|
| Morisset Valerie |
EVP, R&D AND CSO |
• – – |
2024-07-01 |
4 |
OE |
$0.00 |
$2 |
D/D |
7,649 |
512,956 |
|
- |
|
| Shah Rajeev M. |
Director |
– • • |
2024-06-27 |
4 |
B |
$3.84 |
$49,952,817 |
I/I |
13,008,546 |
2,866,375 |
2.25 |
- |
|
| Shah Rajeev M. |
Director |
– • • |
2024-06-27 |
4 |
A |
$0.00 |
$0 |
I/I |
5,259,872 |
1,807,000 |
|
- |
|
38 Records found
|
|
Page 1 of 2 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
